|
PSMB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8708000000256E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.10829999999618E-05 |
| Normal-vs-Stage2 |
6.034200E-02 |
| Normal-vs-Stage3 |
7.178200E-04 |
| Normal-vs-Stage4 |
8.334000E-02 |
| Stage1-vs-Stage2 |
7.676400E-01 |
| Stage1-vs-Stage3 |
6.619600E-02 |
| Stage1-vs-Stage4 |
3.536200E-01 |
| Stage2-vs-Stage3 |
1.070620E-01 |
| Stage2-vs-Stage4 |
3.224000E-01 |
| Stage3-vs-Stage4 |
9.980400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.25680000001771E-06 |
| Normal-vs-AfricanAmerican |
2.500000E-03 |
| Normal-vs-Asian |
1.661610E-01 |
| Caucasian-vs-AfricanAmerican |
4.590000E-01 |
| Caucasian-vs-Asian |
3.735600E-01 |
| AfricanAmerican-vs-Asian |
3.250000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.768200E-04 |
| Normal-vs-Female |
1.73959999738571E-08 |
| Male-vs-Female |
1.840260E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.182780E-03 |
| Normal-vs-Extreme_Weight |
1.378990E-04 |
| Normal-vs-Obese |
4.594900E-04 |
| Normal-vs-Extreme_Obese |
8.724600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.755800E-01 |
| Normal_Weight-vs-Obese |
4.716800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.192020E-01 |
| Extreme_Weight-vs-Obese |
8.302000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.556200E-02 |
| Obese-vs-Extreme_Obese |
1.229170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.204100E-03 |
| Normal-vs-Age(41-60Yrs) |
7.81350000000902E-05 |
| Normal-vs-Age(61-80Yrs) |
8.36350000000818E-05 |
| Normal-vs-Age(81-100Yrs) |
1.106800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.699960E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.840300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.291700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.499600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.123000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.564200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.805000E-04 |
| Normal-VS-Type2 PRCC |
9.048800E-04 |
| Normal-VS-KIRP CIMP |
7.202600E-03 |
| Normal-VS-Unclassified PRCC |
6.43940000000232E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.158000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.691500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.222400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.982100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.099200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.090500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.807300E-04 |
| Normal-vs-N1 |
7.584500E-04 |
| Normal-vs-N2 |
1.634420E-01 |
| N0-vs-N1 |
6.970000E-02 |
| N0-vs-N2 |
2.708400E-01 |
| N1-vs-N2 |
1.751770E-01 |
|
|
